C-erbb-2 oncoprotein and epidermal growth factor receptor in cervical lesions

Pathobiology

Volumn 65, Issue 3, 1997, Pages 163-168

  Lakshmi, S ^a   Nair, M Balaraman ^c   Jayaprakash, P G ^b   Rajalekshmy, T N ^d   Nair, M Krishnan ^b   Pillai, M Radhakrishna ^a  

^a Division of Laboratory Medicine   (India)

^b Department of Head Hand and Neck Oncology   (India)

^c Department of Pathology and Doctors Diagnostic and Research Centre ^*  (India)

^d Department of Obstetrics   (India)

Author keywords

C erbB 2; Cervical cancer; EGF R; Histology

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; CANCER GRADING; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; CARCINOMA IN SITU; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; UTERINE CERVICAL NEOPLASMS;

EID: 0030610019     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164118     Document Type: Article

References (40)

1. Parkin DM. Pisani P. Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993:54:594-600.
2. Spom MB. Roberts AB: Autocrine growth factors and cancer. Nature 1985:313:745-747.
3. Tahara E: Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 1990; 116:121-131.
4. Gustcrson B. Cowley G. Smith JA. Bradford O: Cellular localization of tumor epidermal growth factor receptor. Cell Biol Rep 1984:8: 649-657.
5. Yamamoto T, Kamata N, Kawano H, Shimuzu S, Kuroki T, Toyoshima K. Rikimaru K. Nomura N, Ishizaki R. Pastan L, Gamou S. Shimizu N: High incidence of amplification of growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res 1986: 46:414-416.
6. Ozanne B. Richards CS. Hendlcr F. Burns D. Gustcrson B: Overexpression of the EGF receptor is a hall mark of squamous cell carcinomas. J Pathol 1986;149:9-14.
7. Berglcr W. Bier H. Ganzer U: The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer. Arch Oto-rhinolarvngo 1989,246:121-125.
8. Kannan S. Balaram P. Chandran GJ. Pillai MR. Mathew B, Nair MK: Co-expression of ras p21 and epidermal growth factor receptor during various stages of tumor progression in oral mucosa. Tumor Biol 1994; 15:73-81.
9. Berger MS. Gullick WJ. Greenfield C, Evans S. Addis BJ. Walerfield MD: Epidermal growth factor receptors in lung tumors.,.1 Pathol 1987; 152:297-307.
10. Miyamoto M. Sugawa H. Mori T. Hase K. Kuma K. Imura H: Epidermal growth factor receptors on cultured neoplastic human thyroid cells and effects of epidermal growt h factor and thyroid stimulating hormone on their growth. Cancer Res 1988:48:3652-3656.
11. Sainsbury JRC. Malcom AJ. Appleton DR. Famdon JR. Harris Al: Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985:38:1225-1231.
12. Gullick WJ. Marsden J J. Whittle N, Ward B, Bobrow L, Walerfield M: Expression of epidermal growth factor receptors on human cervical, ovarian and vulvar carcinomas. Cancer Res 1986:46:285-292.
13. Halls RJ. Buckley CH. Gullick WJ. Fox H. Williams J, Wilcox FL: Prognostic value of epidermal growth factor receptor expression in cervical carcinoma. J Clin Pathol 1993:46:153.
14. Kay EW. Walsh CJB. Cassidy M. Curran B. Leader M: c-erbB-2 immunostaining: Problems with interpretation. J Clin Pathol 1994; 47:816-822.
15. Mori S. Akiyama T, Yamada Y. Morishita Y. Sugawara I, Toyoshima K: cerbB-2 gene product. a membrane protein commonly expressed on human fetal epithelial cells. Lab Invest 1989:61:93-97.
16. King CR. Kraus MH. Aaronson SA: Amplification of a novel v-erbB related gene in human mammary carcinoma. Science 1985:229:974-976.
17. Mansour EG. Ravdin PM. Dressier L: Prognostic factors in early breast carcinoma. Cancer 1994:74:381-400.
18. Riviirc A. Becker J. Lotting T: Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer. Cancer 1991:67:2142-2149.
19. Walker RA. Gullick WJ. Varley JM: An evaluation of immunorcactivity for c-erbB-2 protein as a marker of poor short term prognosis in breast cancer. BrJ Cancer 1989:60:426-429.
20. Wright C, Angus B. Nicholson S. Sainsbury JRC. Cairns J. Gullick WJ. Kelly P. Harris AL. Horne CH: Expression of c-crbB2 oncoprotein: A prognostic indicator in human breast cancer. Cancer Res 1989:49:2087-2090.
21. Ali IU. Campell G, Liderau C, Callahan R: Amplification of c-erbB2 and aggressive human breast tumors. Science 1988:240:1795-1796.
22. Lemoinc NR. Wyllie FS, Lillehaugc JR. Stad-don SL. Hughes CM. Aasland R. Shaw J. Var-haug JE. Brown CL. Gullick WJ. Wynford-Thontas D: Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia. Eur J Cancer 1990:26: 777-779.
23. Jain S, Felipe MI, Gullick WJ. Linehan J. Morris RW: c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: An immunohistochemical study on archival material. Int J Cancer 1991:48:668-671.
24. Wrba F, Gullick WJ. Fcrtl II. Amann G. Sal-zer-Kuntschik M: Immuno-histochemical detection of the c-erbB-2 proto-oncogene product in normal benign and malignant cartilage tissue. Histopathology 1988:15:71-76.
25. Salmon DJ. Godolphin W. Jones LA: Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989:244: 707-712.
26. Coombs LM. Piggott DA, Sweeney E: Amplification and over-expression of c-erbB2 in transitional cell carcinoma Of the urinary bladder. Br J Cancer 1991;63:601-608.
27. Hall PA, Huges CM, Staddon SL, Richman PI. Gullick WJ. Lemoinc NR: The c-erbB2 protooncogene in human pancreatic cancer. J Pathol 1990:161:194-200.
28. Yokota J, Yamamoto T, Toyoshima K. Sujimura T, Tarada M. Battifora H, Cline MJ: Amplification of c-erbB2 oncogene in human adenocarcinoma in vivo. Lancet 1986;i:765-766.
29. Kemohan NM, Blessing K. King G: Expression of c-erbB2 oncoprotein in salivary gland tumors: An immunohistochemical study. J Pathol 1991;163:77-80.
30. Lakshmi S. Nair MB. Rajalekshmi TN, Jaya-prakash PG, Nair MK, Pillai MR: Proliferating cell nuclear antigen and the progression of cervical intraepithelial neoplasia. Oncol Rep 1996;3:1195-1198.
31. Kannan S. Balaram P. Chandran GJ, Pillai MR. Mathew B, Nair MK: Co-expression of ras p21 and epidermal growth factor receptor during various stages of tumor progression in oral mucosa. Tumor Biol 1994; 15:73-81.
32. Goppingcr A. Wittmaack FM, Wintzer HO. Ikenberg H, Bauknccht T: Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias. J Cancer Res Clin Oncol 1989:115:259-263.
33. Hunts J. Ucda M, Ozawa S, Osahiko O, Pastan I. Shimizu N: Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas. Jpn J Cancer Res 1985;76:663-666.
34. Kagiyama R, Merlino G. Pastan I: Epidermal growth factor receptor gene transcription. Br J Cancer 1988:263:6329-6336.
35. Pfeiffer D. Stcllwag B. Pfeiffer A. Birlingaus P. Meier W. Scheidel P: Clinical implications of the epidermal growth factor in squamous cell carcinoma of the uterine cervix. Gynecol Oncol 1989;33:146-150.
36. Berchuck A, Rodriguez G. Kamel A. Soper JT. Carke-Pearson DL. Bast RC: Expression of epidermal growth factor and Her-2/ncu in normal and neoplastic cervix, vulva and vagina. Obstct Gynecol 1990;76:381-387.
37. Marua T, Yamasaki M, Ladines-Llave CA. Mochizuki M: Immunohistochemical demonstration of elevated expression of epidermal growih factor receptor in the neoplastic changes of cervical squamous epithelium. Cancer 1992;69:1182-1187.
38. Hale RJ. Buckley CH, Fox H, Williams J: Prognostic value of c-erb B2 expression in uterine cervical carcinoma. J Clin Pathol 1992:45: 594-596.
39. Brumm C, Riviere A, Wickens C. Loning T: Immunohistochemical investigation and Northern blot analysis of e-crbB-2 expression in normal, premalignant and malignant tissue of corpus and cervix uteri. Virchows Arch A 1990:417:477-484.
40. Oka K, Nakano T, Arai T: c-crbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix. Cancer 1994;73:668-671.